Please use this identifier to cite or link to this item:
Title: The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Issue Date: 2018
Citation: Ann Clin Transl Neurol.2018 06;(5)6:710-716
Abstract: To evaluate whether the clinical benefit and relapse rates in anti-muscle-specific kinase (MuSK) myasthenia gravis (MG) differ depending on the protocol of rituximab followed.
PMID: 29928654
Rights: openAccess
ISSN: 2328-9503
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC5989782.pdf174.17 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.